v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Jul. 31, 2025
Jul. 31, 2024
Cash flows from operating activities:    
Net loss $ (162,031) $ (117,178)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation 8,657 9,227
Depreciation and amortization 30,582 27,389
Non-cash interest expense on finance obligations 1,773 1,633
Unrealized (gain) loss on derivative contracts (1,862) 8,267
Operating lease costs 1,005 1,052
Operating lease payments (1,030) (931)
Impairment expense 64,467 1,107
Other, net 180 229
Decrease (increase) in operating assets:    
Accounts receivable 1,801 (7,352)
Unbilled receivables (33,110) (7,976)
Inventories (2,058) (44,893)
Other assets (10,019) (33,337)
(Decrease) increase in operating liabilities:    
Accounts payable (3,943) (5,985)
Accrued liabilities (258) 507
Deferred revenue 3,419 9,490
Net cash used in operating activities (102,427) (158,751)
Cash flows from investing activities:    
Capital expenditures (17,586) (37,176)
Project asset expenditures (3,845) (11,769)
Maturity of held-to-maturity debt securities 772,370 506,770
Purchases of held-to-maturity debt securities (660,969) (476,803)
Net cash provided by (used in) investing activities 89,970 (18,978)
Cash flows from financing activities:    
Repayment of debt and finance obligations (10,424) (8,782)
Proceeds from the issuance of debt   13,000
Payment for deferred financing costs (171) (343)
Common stock issued for stock plans and related expenses 51 120
Contributions received from sale of noncontrolling interest 4,000 25,122
Distribution to noncontrolling interest (1,638) (1,146)
Payments for taxes related to net share settlement of equity awards (507) (1,072)
Common stock issuance, net of fees 51,626 71,739
Payment of preferred dividends (2,400) (2,400)
Net cash provided by financing activities 40,537 96,238
Effects on cash from changes in foreign currency rates (109) 96
Net increase (decrease) in cash, cash equivalents and restricted cash 27,971 (81,395)
Cash, cash equivalents and restricted cash-beginning of period 208,883 299,576
Cash, cash equivalents and restricted cash-end of period $ 236,854 $ 218,181